Probiotics: multifarious oral vaccine against infectious traumas (Q37681016)

21 August 2017

1 reference

title

Probiotics: multifarious oral vaccine against infectious traumas (English)

1 reference

21 August 2017

0 references

Sarika Amdekar

1

1 reference

21 August 2017

Deepak Dwivedi

2

1 reference

21 August 2017

Purabi Roy

3

1 reference

21 August 2017

Sapna Kushwah

4

1 reference

21 August 2017

Vinod Singh

5

1 reference

21 August 2017

publication date

6 November 2009

1 reference

FEMS Immunology and Medical Microbiology

21 August 2017

published in

1 reference

21 August 2017

volume

58

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

299-306

1 reference

Toll-like receptors: critical proteins linking innate and acquired immunity

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Rotavirus infection in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Live bacterial vaccines--a review and identification of potential hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Experience with registered mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Probiotics in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Immunization against blood-stage rodent malaria using purified parasite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Effects of stress on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Free radicals and heat shock protein in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Vaccination against enteric pathogens: from science to vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

The mucosal immune system: from fundamental concepts to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Use of Lactobacillus to prevent infection by pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Innate and specific gut-associated immunity and microbial interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Protein, Calories, and Immune Defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.2009.00630.X

10.1111/J.1574-695X.2009.00630.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference